Omnicell

SEPTEMBER 5, 2022

Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell Labelling 52

Omnicell

FEBRUARY 16, 2023

Carmine DeNardo VP and General Manager, Specialty Pharmacy Services, Omnicell Despite the widespread adoption of electronic health records, pharmacy management systems, and other digital technologies, managing patients and medications across the continuum of care remains a significant challenge.

Specialty Pharmacies 52

Specialty Pharmacies Omnicell Hospitals Compounding 52

Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Imagine if Amazon lost one out of every 10 packages. So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterile compounded products? Or the airlines lost 10% of passenger bags.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell Documentation 52

Omnicell

SEPTEMBER 5, 2022

David Webster Director of Acute Care Pharmacy Operations, University of Rochester Medical Center Sterile compounding is one of the most high risk, high cost areas of medication management. Manual compounding is fraught with error, studies indicating 1 in 10 IVs are not prepared according to guidelines.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell 52

Omnicell

JANUARY 10, 2023

Many often rely on 503B outsourcing pharmacies for their pre-mixed compounded sterile products. At the University of Maryland Medical Center, we reduced our need for 503B vendors by implementing an IV robotics insourcing program for compounded sterile products (CSPs).

Compounding 52

Compounding Omnicell Sterile Compounds Hospitals 52

Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.

Compounding 52

Compounding Sterile Compounds Omnicell Patient Care 52

Omnicell

SEPTEMBER 5, 2022

When we talked about IV room compounding, I’ll never forget them telling me, “Making IVs is not like making pizzas at the local sub shop.” ” It’s not a big deal if you mix up sausage and pepperoni on a pizza, but one misstep in manual IV compounding could be absolutely devastating to a patient.

Compounding 52

Compounding Sterile Compounds Omnicell Hospitals 52

Omnicell

JANUARY 10, 2023

Michael Korthuis Vice President of Engineering, Omnicell The changing nature of healthcare and the shift toward value-based care has led to a growing focus on better cost management while improving care. Visit Omnicell at booth #5767 during HIMSS22 , March 14-18 in Orlando.

Omnicell 98

Omnicell Compounding Hospitals 98

Omnicell

JANUARY 10, 2023

Director Product Marketing & Development, Omnicell With drug costs skyrocketing and the ever-present challenge of drug shortages, throwing away medications can be agonizing. For example, the Omnicell XR2 Automated Central Pharmacy System has advanced algorithms that ensure earliest expiring medications are dispensed first.

Omnicell 98

Omnicell Compounding 98

Omnicell

JANUARY 10, 2023

Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. Sterile compounding is also one of the costliest functions in pharmacy operations. Insourcing IV compounding services at Moses H.

Sterile Compounds 52

Sterile Compounds Omnicell Compounding Hospitals 52

Omnicell

JANUARY 10, 2023

Mitch Mayo Product Marketing Manager, Omnicell In healthcare, you know it's sometimes challenging to connect diverse healthcare systems, including those involving different types of care, care settings, payer requirements, patient populations, and more. Need a partner to assist in the journey to systemness?

Omnicell 98

Omnicell Patient Care Compounding 98

Omnicell

JANUARY 10, 2023

Ken Osborn Senior Director, Product Marketing, Omnicell As medication management continues to be one of the top challenges of healthcare today, Omnicell’s commitment to delivering the innovation to navigate and streamline the complexities of the pharmacy care delivery model is stronger than ever.

Controlled Substances 52

Controlled Substances Omnicell Compounding Sterile Compounds 52

Omnicell

JANUARY 10, 2023

Dennis Wright Senior Director, Central Pharmacy Product Marketing, Omnicell As one of the early adopters of the vision of Autonomous Pharmacy , Texas Children's Hospital in Houston saw the opportunity for connected automation, intelligent data, and technology-enabled services to drive radical change in their medication management strategy.

Omnicell 52

Omnicell Sterile Compounds Compounding Hospitals 52

Omnicell

SEPTEMBER 5, 2022

Juliana Linsdell, BSN, RN Omnicell Nurse Consultant For our customer, Massachusetts General Hospital – the No. “That’s why we rely so heavily on our Omnicell cabinets. . “That’s why we rely so heavily on our Omnicell cabinets. Bottom line: Pennell knows intelligent cabinets are a smart investment.

Omnicell 52

Omnicell Hospitals Compounding Patient Care 52

Omnicell

SEPTEMBER 5, 2022

The operational blind spots caused by disconnected, siloed systems compounded by the delays and errors caused by outdated manual workflows are the hallmarks of operational complexity that impedes ideal perpetual inventory management and leads to financial strains that plague pharmacies.

Controlled Substances 98

Controlled Substances Omnicell Patient Care Hospitals 98

Omnicell

SEPTEMBER 5, 2022

Joy Somogyi Senior Director of Product Marketing and Development, Omnicell With two million people suffering from opioid addiction and 115 people dying from an opioid overdose every day in the U.S., the opioid crisis is one of the major challenges healthcare is facing, specifically for pharmacies currently managing medication diversion.

Omnicell 52

Omnicell Controlled Substances Hospitals Documentation 52

Omnicell

JANUARY 10, 2023

Arpit Mehta Director of Pharmacy, Allegheny General Hospital Like many health systems, we at Allegheny Health Network have been challenged by the cost, compliance, and complexity of compounding sterile products (CSPs). Omnicell's IV compounding robot service offered the holistic solution we needed.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell Hospitals 52

Omnicell

JANUARY 10, 2023

Denise Cox SVP, Chief Customer Officer, North America, Omnicell Women currently hold more than 75% of all healthcare jobs in the United States, versus just 8% in the 1960s. Implications for women of color are even worse, with only 5% of C-suite positions held by minority women.

Omnicell 52

Omnicell Compounding Communication Hospitals 52

Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Despite the reality that intravenous (IV) compounding is among the highest risk areas in the continuum of acute care when it comes to the potential for possible patient harm, IV systems are often the last to be impacted by advances in pharmacy automation.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell Hospitals 52

Omnicell

JANUARY 10, 2023

Jim Longo Senior Manager, Value Management, Omnicell Today’s healthcare environment is highly unpredictable. The ongoing effects of increasing expenses, downward pressure on revenue and reimbursement, and compressed operating margins are compounded by wildcards like the COVID-19 pandemic.

Omnicell 52

Omnicell Compounding 52

Omnicell

JANUARY 10, 2023

Howard Montgomery, MS, RPh Director, Clinical Consulting, Omnicell The biggest vaccination campaign in history is now underway and scaling fast. The vaccine is finally here, and Omnicell is committed to helping you effectively manage and support a smooth rollout to your patients. million shots have been administered in the U.S.

Vaccines 52

Vaccines Omnicell Documentation Compounding 52

Omnicell

SEPTEMBER 5, 2022

In the premier episode of Omnicell’s The Future of Pharmacy Podcast , I join Omnicell’s Jim Stevenson, Vice President of Medication System Strategy, and host Ken Perez, to discuss the opportunity of Autonomous Pharmacy to help us achieve our patient care goals. And that study was before the coronavirus pandemic hit.

Omnicell 52

Omnicell Patient Care Hospitals Compounding 52

Omnicell

SEPTEMBER 5, 2022

Mark Neuenschwander Founding Director, THRIVCoalition.org Seminal research from 1997 on IV compounding discovered that 9 percent of manually compounded sterile preparations had incorrect ingredients and/or volumes. Worst yet, 74% of all respondents were aware of at least one pharmacy compounding error in the last 12 months.

Compounding 52

Compounding Sterile Compounds Documentation Compounding Pharmacies 52

Omnicell

JANUARY 10, 2023

Director Product Marketing & Development, Omnicell I recently spoke with Dr. Shafiq Rab , MBBS, MPH, CHCIO, FCHIME , Chief Digital Officer and System  CIO at Wellforce , about his perspectives on digital transformation and culturally competent care. I nefficient workflows and lack of data visibility compound Pharmacy challenges.

Compounding Pharmacies 52

Compounding Pharmacies Omnicell Compounding Communication 52

Omnicell

JANUARY 10, 2023

Ken Perez Vice President, Healthcare Policy, Omnicell Overreliance on manual processes and siloed technology in pharmacy operations are among the biggest challenges facing health systems today.

Omnicell 52

Omnicell Compounding Hospitals 52

Omnicell

MARCH 27, 2023

Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospital patient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion.

Sterile Compounds 52

Sterile Compounds Medication Dispensing Omnicell Hospitals 52

Omnicell

FEBRUARY 14, 2023

Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospital patient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion.

Sterile Compounds 52

Sterile Compounds Medication Dispensing Omnicell Hospitals 52

Omnicell

JANUARY 10, 2023

Omnicell is partnering with the Autonomous Pharmacy Advisory Board to transform the pharmacy care model through technology-enabled solutions and delivering expert services, supporting the journey to “zero error” through the Autonomous Pharmacy.

Hospitals 52

Hospitals Sterile Compounds Omnicell Patient Care 52

Omnicell

JANUARY 10, 2023

The latest advancements in managing medications within the last few years, such as IV compounding robot , has advanced the delivery of IV medications and removed human error to ensure accurate IV doses and accurate labeling of the solutions. 

Patient Care 52

Patient Care Controlled Substances Medication Delivery Hospitals 52

Omnicell

JANUARY 10, 2023

Congressional Democrats' challenges are compounded by a relatively unpopular president. Strikingly, "the Republicans' five-point edge in party preference is the largest they have established over the Democrats since 1995—right after the GOP took control of the House for the first time in four decades." Other polls show similar trends.

Hospitals 52

Hospitals Compounding 52